DICUMAROL manufacturers and suppliers

DICUMAROL suppliers

Properties

Melting point:: 290-292 °C(lit.)

Boiling point:: 392.79°C (rough estimate)

Density: 1.2864 (rough estimate)

refractive index: 1.4450 (estimate)

storage temp.: Sealed in dry,Room Temperature

solubility: DMSO:3.06(Max Conc. mg/mL);9.1(Max Conc. mM)
DMSO:PBS (pH 7.2) (1:1):0.5(Max Conc. mg/mL);1.49(Max Conc. mM)
DMF:1.25(Max Conc. mg/mL);3.72(Max Conc. mM)
Water:50.0(Max Conc. mg/mL);148.68(Max Conc. mM)

pka: 4.20±1.00(Predicted)

form: Fine Crystalline Powder

color: White

biological source: synthetic (organic)

Water Solubility: Soluble in aqueous alkaline solutions, organic bases, 0.1 N NaOH (15 mg/ml), Pyridine (50 mg/ml), chloroform (slightly soluble), and benzene (slightly soluble). Insoluble in water, and alcohols.

Merck: 14,3090

InChI: 1S/C19H12O6/c20-16-10-5-1-3-7-14(10)24-18(22)12(16)9-13-17(21)11-6-2-4-8-15(11)25-19(13)23/h1-8,20-21H,9H2

InChIKey: DOBMPNYZJYQDGZ-UHFFFAOYSA-N

SMILES: [o]1c2c(c(c([c]1=O)Cc3[c]([o]c4c(c3O)cccc4)=O)O)cccc2

EPA Substance Registry System: 2H-1-Benzopyran-2-one, 3,3'-methylenebis[4-hydroxy- (66-76-2)

Safety Information

Symbol(GHS): GHS06,GHS08,GHS09

Signal word: Danger

Hazard statements: H301-H372-H411

Precautionary statements: P260-P264-P270-P273-P301+P310-P314

Hazard Codes: T,N

Risk Statements: 22-48/25-51/53

Safety Statements: 37-45-61

RIDADR: UN 2811 6.1/PG 3

WGK Germany: 3

RTECS: GN7875000

TSCA: TSCA listed

HazardClass: 6.1(b)

PackingGroup: III

HS Code: 29322985

Storage Class: 6.1C - Combustible acute toxic Cat.3
toxic compounds or compounds which causing chronic effects

Hazard Classifications: Acute Tox. 3 Oral
Aquatic Chronic 2
STOT RE 1 Oral

Hazardous Substances Data: 66-76-2(Hazardous Substances Data)

Toxicity: LD50 orally in rats: 541.6 mg/kg (Rose)

Use

Dicumarol is used alone or as an adjunct to heparin in theprophylaxis and treatment of intravascular clotting. It is usedin postoperative thrombophlebitis, pulmonary embolus, acuteembolic and thrombotic occlusion of peripheral arteries, andrecurrent idiopathic thrombophlebitis. It has no effect on analready-formed embolus but may prevent further intravascularclotting. Because the outcome of acute coronary thrombosisdepends largely on extension of the clot and formation ofmural thrombi in the heart chambers, with subsequent embolization,dicumarol has been used in this condition. It hasalso been administered to arrest impending gangrene afterfrostbite. The dose, after determination of the prothrombinclotting time, is 25 to 200 mg, depending on the size and thecondition of the patient. The drug is given orally in the formof capsules or tablets. On the second day and thereafter, itmay be given in amounts sufficient to maintain the prothrombinclotting time at about 30 seconds. If hemorrhages shouldoccur, a dosage of 50 to 100 mg of menadione sodium bisulfiteis injected, supplemented by a blood transfusion.

You can find DICUMAROL suppliers, manufacturers, and distributors from countries such as CHINA, United States and the United Kingdom here. Browse to the tetrahydrofuran product information displayed by the supplier, as well as the supplier's contact and capability information.